Patents Assigned to SHENOX PHARMACEUTICALS, LLC
  • Ketamine transdermal delivery system
    Patent number: 11191734
    Abstract: The present invention is directed to a transdermal delivery device comprising ketamine and formulations thereof. The present invention is also directed to a transdermal delivery device comprising ketamine for the treatment of major depressive disorder (MDD) and/or pain. The present invention is further directed to a transdermal delivery device comprising ketamine and abuse deterrent agents.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: December 7, 2021
    Assignee: SHENOX PHARMACEUTICALS, LLC
    Inventors: Huadong Tang, Hock S. Tan, Michael Mayersohn